AstraZeneca-Daiichi Breast Cancer Drug Cuts Disease Progression Or Death Risk By Almost 50%
19 days agoGSK Confirms Consumer Healthcare Unit Spin-off: What Investors Should Know
24 days agoAttention Biotech Investors: Mark Your Calendar For These June PDUFA Dates
24 days agoMurder For Hire? What You Need To Know About Enochian Biosciences Co-Founder's Arrest
30 days agoBiotech Recent News
Filsuvez's European Approval Adds Growth Driver For Amryt Pharma
Intellia's Gene-Editing Candidate Shows Durability In ATTR Amyloidosis
U.S. FDA Accepts Emergent's Anthrax Vaccine Candidate Filing For Review
Adverum Biotech Receives EMA's Priority Medicines Status For Chronic Eye Disorder Candidate
Eton Pharma Shares Tick Higher After Offloading Hospital Products
The Daily Biotech Pulse: European Backing For Novavax's COVID-19 Shot In Adolescents, Sanofi-GSK's Updated Vaccine Effective Against Omicron, FDA's Clinical Hold On Sarepta's Duchenne Trial
SciSparc Receives Ethics Committee Approval To Conduct Clinical Trial In ASD With Proprietary SCI-210 Treatment
Sponsored
ASCO Annual Meeting 2022: An Innovation Showcase In Cancer Treatment
Sponsored
Moderna Has Multi-Billion-Dollar Opportunity Outside Of COVID-19 Vaccines, Analyst Says
Merck/Seagen Potential Deal Talks Pick Up Speed: WSJ
Sanofi-GSK's Beta-Containing COVID-19 Vaccine Shows Efficacy Against Omicron
Calithera Commences Mid-Stage Study Of DLBCL Candidate
Sarepta Therapeutics' Shares Plummet Following FDA's Clinical Hold On MOMENTUM Study
Why Did HC Wainwright Downgrade Addex Therapeutics
Novartis Announces $250M In R&D Funding For Neglected Tropical Diseases, Malaria
FDA Gives Approval For Novartis' Tafinlar + Mekinist Broadens BRAF/MEK Cancer Combo Use
BioNTech Gets EMA's Priority Medicines Status For Testicular Cancer Drug
UniQure Shares Are Up After Low-Dose Cohort Data From Huntington's Gene Therapy Trial
RedHill Biopharma Shares Trading Higher On Improved Q1 Profitability
AstraZeneca's ALXN1840 Shows Promising Action Against Copper Metabolism Disorder
Evaxion Biotech To Test EVX-03 DNA Vaccine For Non-Small Cell Lung Cancer
Bone Health Focused Radius Health Goes Private In $890M Deal
SciSparc Announces Ethics Committee Approval To Conduct Its Clinical Trial In Autism Spectrum Disorder
Sponsored
SIGA Technologies Announces $13M Worth Order For Its Monkeypox Treatment
The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise
Cognition Therapeutics Begins Mid-Stage Study Of Neurological Disorder Candidate
F-star Therapeutics Shares Are Rallying Today - Read Why
How Babylon, One Of The Fastest-Growing Digital Healthcare Companies In The World, Is Looking To Make Healthcare More Accessible And Affordable For Everyone
BioStem Technologies' Local MicroEnvironment Activation Possible Key To Reversing And Repairing Diseases-Caused Tissue Damage
InMed Pharmaceuticals: The Clinical-Stage Company Setting Sites On Dominating Rare Cannabinoid Production And Commercialization Across Global Markets